Premium
Dose‐response effect of hazelnut consumption on body composition and inflammatory markers in overweight and obese individuals
Author(s) -
Tey Agnes Siew Ling,
Brown Rachel,
Gray Andrew,
Chisholm Alexandra,
Delahunty Conor
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.1033.16
Subject(s) - overweight , obesity , medicine , composition (language) , inflammation , philosophy , linguistics
Recent evidence suggests regular nut consumption may have beneficial effects on cardiovascular disease risk factors that go beyond their cholesterol‐lowering properties, e.g. a reduction in inflammation. Inflammation is more pronounced amongst overweight and obese populations. Current guidelines in New Zealand recommend the daily consumption of 30g of nuts. Studies are lacking regarding the quantity of nuts required to confer anti‐inflammatory properties without compromising the body weight. Thus, the objective of this study was to compare the effects of incorporating hazelnuts at two different doses with a diet without nuts on body composition and inflammatory markers in 110 overweight and obese individuals. The study was conducted using a randomised, controlled, parallel design including three treatment arms: 30 g/d of hazelnuts, 60 g/d of hazelnuts or no nuts (control group) for 12 weeks. Body composition and inflammatory markers were assessed at baseline, 6 weeks and 12 weeks. There was no evidence of any differences in follow‐up measurements between groups after adjusting for baseline values. Hazelnut consumption does not adversely affect body composition but appears to have no effect on inflammatory markers in overweight and obese individuals.